TickerFacts.

YD Bio Ltd (YDES): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$2.86M
As of 2025-12-31
$6.59M2023-12-31: $23.0K2024-12-31: $6.59M2025-12-31: -$2.86M-$2.86M
2023-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$2.86Mn/m2026-04-30, Balance as of period end
2024-12-31$6.59Mn/m2026-04-30, Balance as of period end
2023-12-31$23.0Kn/a2026-04-30, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
YD Bio Ltd (YDES)2025-12-31-$2.86Mn/m
Sera Prognostics, Inc. (SERA)2025-12-31$75.41M+57.7%
Aclarion, Inc. (ACON)2025-12-31$12.84Mn/m
BioNexus Gene Lab Corp (BGLC)2025-12-31$8.61M+3.5%
American Shared Hospital Services (AMS)2025-12-31$27.69M-7.8%
CapForce Inc. (CFOR)2025-12-31$31.86M+331.6%
Exagen Inc. (XGN)2025-12-31$17.45M+82.9%
Personalis, Inc. (PSNL)2025-12-31$261.19M+28.7%
Biodesix Inc (BDSX)2025-12-31-$2.46Mn/m

Compare YDES, SERA, ACON, BGLC side by side · Screen every company in Services-Medical Laboratories ↗